Generation and Culture of Organotypic Breast Carcinoma Spheroids for the Study of Drug Response in a 3D Microfluidic Device.
- Publisher:
- Humana Press
- Publication Type:
- Journal Article
- Citation:
- Methods in Molecular Biology, 2022, 2535, pp. 49-57
- Issue Date:
- 2022
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| 20349885_10071216110005671.pdf | Published version | 421.43 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
| Field | Value | Language |
|---|---|---|
| dc.contributor.author | Aboulkheyr Es, H | |
| dc.contributor.author | Aref, AR | |
| dc.contributor.author | Warkiani, ME | |
| dc.date.accessioned | 2023-03-05T01:27:14Z | |
| dc.date.available | 2023-03-05T01:27:14Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Methods in Molecular Biology, 2022, 2535, pp. 49-57 | |
| dc.identifier.isbn | 9781071625125 | |
| dc.identifier.issn | 1064-3745 | |
| dc.identifier.issn | 1940-6029 | |
| dc.identifier.uri | http://hdl.handle.net/10453/166664 | |
| dc.description.abstract | Breast cancer (BC) is a leading cause of cancer death among women worldwide. To better understand and predict therapeutic response in BC patient developing a fast, low-cost, and reliable preclinical tumor from patient's tumor specimen is needed. Here, we describe the development of a preclinical model of BC through the generation and ex vivo culture of patient-derived organotypic tumor spheroids (PDOTS) in a 3D microfluidic device. Moreover, the real-time screening of conventional chemotherapy agents on cultured PDOTS is also described. | |
| dc.format | ||
| dc.language | eng | |
| dc.publisher | Humana Press | |
| dc.relation | http://purl.org/au-research/grants/nhmrc/1143377 | |
| dc.relation.ispartof | Methods in Molecular Biology | |
| dc.relation.isbasedon | 10.1007/978-1-0716-2513-2_4 | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | 0399 Other Chemical Sciences, 0601 Biochemistry and Cell Biology | |
| dc.subject.classification | Developmental Biology | |
| dc.subject.mesh | Breast Neoplasms | |
| dc.subject.mesh | Cell Culture Techniques | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Lab-On-A-Chip Devices | |
| dc.subject.mesh | Microfluidic Analytical Techniques | |
| dc.subject.mesh | Spheroids, Cellular | |
| dc.subject.mesh | Breast Neoplasms | |
| dc.subject.mesh | Cell Culture Techniques | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Lab-On-A-Chip Devices | |
| dc.subject.mesh | Microfluidic Analytical Techniques | |
| dc.subject.mesh | Spheroids, Cellular | |
| dc.subject.mesh | Spheroids, Cellular | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Breast Neoplasms | |
| dc.subject.mesh | Microfluidic Analytical Techniques | |
| dc.subject.mesh | Cell Culture Techniques | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Lab-On-A-Chip Devices | |
| dc.subject.mesh | Breast Neoplasms | |
| dc.subject.mesh | Cell Culture Techniques | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Lab-On-A-Chip Devices | |
| dc.subject.mesh | Microfluidic Analytical Techniques | |
| dc.subject.mesh | Spheroids, Cellular | |
| dc.title | Generation and Culture of Organotypic Breast Carcinoma Spheroids for the Study of Drug Response in a 3D Microfluidic Device. | |
| dc.type | Journal Article | |
| utslib.citation.volume | 2535 | |
| utslib.location.activity | United States | |
| utslib.for | 0399 Other Chemical Sciences | |
| utslib.for | 0601 Biochemistry and Cell Biology | |
| pubs.organisational-group | /University of Technology Sydney | |
| pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology | |
| pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
| pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering | |
| pubs.organisational-group | /University of Technology Sydney/Strength - IBMD - Initiative for Biomedical Devices | |
| pubs.organisational-group | /University of Technology Sydney/Centre for Health Technologies (CHT) | |
| utslib.copyright.status | closed_access | * |
| pubs.consider-herdc | false | |
| dc.date.updated | 2023-03-05T01:27:13Z | |
| pubs.publication-status | Published | |
| pubs.volume | 2535 |
Abstract:
Breast cancer (BC) is a leading cause of cancer death among women worldwide. To better understand and predict therapeutic response in BC patient developing a fast, low-cost, and reliable preclinical tumor from patient's tumor specimen is needed. Here, we describe the development of a preclinical model of BC through the generation and ex vivo culture of patient-derived organotypic tumor spheroids (PDOTS) in a 3D microfluidic device. Moreover, the real-time screening of conventional chemotherapy agents on cultured PDOTS is also described.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph
